311690 — CJ Bioscience Share Price
0.000.00%
Last trade - 00:00- KR₩110bn
- KR₩69bn
- KR₩6bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.95 | ||
| Price to Tang. Book | 2.51 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 22.36 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -50.36% | ||
| Return on Equity | -47.56% | ||
| Operating Margin | -628.61% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 4,783.22 | 5,311.55 | 4,363.03 | 4,074.66 | 5,575.05 | n/a | n/a | 7.28% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CJ Bioscience Inc, formerly ChunLab Inc, is a Korea-based company principally engaged in the provision of microbial bioinformatics platform and solutions. The Company mainly provides microbial bioinformatics analysis services and microbiome-based healthcare services through bioinformatics database and cloud analytics platform. The Company also develops microbiome therapies and infection diagnosis solutions.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- November 18th, 2009
- Public Since
- December 26th, 2019
- No. of Shareholders
- 9,632
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 9,112,502
- Address
- 7F, B Dong, Grand Central Tower, SEOUL, 04527
- Web
- https://www.cjbioscience.com/
- Phone
- +82 260783456
- Auditors
- Shinhan Accounting Corporation
Upcoming Events for 311690
Similar to 311690
ABion
Korea Exchange - KOSDAQ
ABL Bio
Korea Exchange - KOSDAQ
Amicogen
Korea Exchange - KOSDAQ
AprilBio Co
Korea Exchange - KOSDAQ
AptaBio Therapeutics
Korea Exchange - KOSDAQ
FAQ
What is the CJ Bioscience share price?
As of Today at 19:58 UTC, shares in CJ Bioscience are trading at KR₩12,020. This share price information is delayed by 15 minutes.
How has the CJ Bioscience share price performed this year?
Shares in CJ Bioscience last closed at KR₩12,020 and the price had moved by -21.27% over the past 365 days. In terms of relative price strength the CJ Bioscience share price has underperformed the FTSE Developed Asia Pacific Index by -31.4% over the past year.
What are the analyst and broker recommendations for CJ Bioscience?
There is no consensus recommendation for this security.
Find out moreWhat is the CJ Bioscience dividend yield?
CJ Bioscience does not currently pay a dividend.
Does CJ Bioscience pay a dividend?
CJ Bioscience does not currently pay a dividend.
When does CJ Bioscience next pay dividends?
CJ Bioscience does not currently pay a dividend.
How do I buy CJ Bioscience shares?
To buy shares in CJ Bioscience you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CJ Bioscience?
As of the previous close price of KR₩12,020, shares in CJ Bioscience had a market capitalisation of KR₩110bn.
Where are CJ Bioscience shares listed?
Here are the trading details for CJ Bioscience:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 311690
What kind of share is CJ Bioscience?
Based on an overall assessment of its quality, value and momentum CJ Bioscience is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CJ Bioscience share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the CJ Bioscience share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CJ Bioscience. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -27.13%.
As of the last closing price of KR₩12,020, shares in CJ Bioscience were trading -14.27% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CJ Bioscience PE Ratio?
The CJ Bioscience PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩12,020.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CJ Bioscience?
We do not have data on CJ Bioscience's directors